Afecta Pharmaceuticals   Report issue

For profit Phase 4
Founded: Irvine CA United States (2002)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03703895
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Afecta Pharmaceuticals